Learn more about the car you're interested in before you buy. Not quite sure where to start? Explore models that fit your needs. See all of the winners and nominees. Winner Nominee Nominee Nominee ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...

Discover a novel approach to reduce relapse rates for blood cancers treated via the revolutionary CAR T-cell therapy.

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

VWAGY, TM, and STLA lead the 10 biggest car companies list Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). The automotive ...

An FDA announcement last year of an investigation into the risk of patients developing secondary cancers following the treatment of CAR-T cell therapies sent shock waves across the industry.

A growing body of research suggests that clinicians can offer chimeric antigen receptor (CAR) T-cell therapy safely and effectively on an outpatient basis — a positive development as clinicians ...

1Division of Oncology, Section of Cellular Therapy, Washington University School of Medicine, St. Louis, Missouri. 2Center for Gene and Cellular Immunotherapy, Washington University School of Medicine ...

No one can doubt that chimeric antigen receptor (CAR)-T therapies have had remarkable success in treating blood cancers. But as the years have passed since their initial approval, questions have ...

Houston, Texas – In a comprehensive review published in the October 2024 issue of Genomic Psychiatry, researchers have unveiled crucial insights into how two types of hormone receptors ...